Winnergy Medical (Thailand) Performance
WINMED Stock | THB 1.95 0.01 0.51% |
Winnergy Medical has a performance score of 5 on a scale of 0 to 100. The firm maintains a market beta of -0.2, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Winnergy Medical are expected to decrease at a much lower rate. During the bear market, Winnergy Medical is likely to outperform the market. Winnergy Medical Public right now maintains a risk of 2.02%. Please check out Winnergy Medical Public maximum drawdown, accumulation distribution, relative strength index, as well as the relationship between the semi variance and day typical price , to decide if Winnergy Medical Public will be following its historical returns.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Winnergy Medical Public are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, Winnergy Medical may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
Begin Period Cash Flow | 8.3 M | |
Total Cashflows From Investing Activities | -136.5 M |
Winnergy |
Winnergy Medical Relative Risk vs. Return Landscape
If you would invest 181.00 in Winnergy Medical Public on August 24, 2024 and sell it today you would earn a total of 14.00 from holding Winnergy Medical Public or generate 7.73% return on investment over 90 days. Winnergy Medical Public is generating 0.1383% of daily returns and assumes 2.0173% volatility on return distribution over the 90 days horizon. Simply put, 17% of stocks are less volatile than Winnergy, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Winnergy Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Winnergy Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Winnergy Medical Public, and traders can use it to determine the average amount a Winnergy Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0686
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | WINMED | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.02 actual daily | 17 83% of assets are more volatile |
Expected Return
0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Winnergy Medical is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Winnergy Medical by adding it to a well-diversified portfolio.
Winnergy Medical Fundamentals Growth
Winnergy Stock prices reflect investors' perceptions of the future prospects and financial health of Winnergy Medical, and Winnergy Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Winnergy Stock performance.
Return On Equity | 0.12 | |||
Return On Asset | 0.0444 | |||
Profit Margin | 0.09 % | |||
Operating Margin | 0.08 % | |||
Current Valuation | 1.84 B | |||
Shares Outstanding | 400 M | |||
Price To Earning | 23.63 X | |||
Price To Book | 3.02 X | |||
Price To Sales | 2.50 X | |||
Revenue | 538.7 M | |||
EBITDA | 110.74 M | |||
Cash And Equivalents | 151.3 M | |||
Cash Per Share | 0.38 X | |||
Total Debt | 64.38 M | |||
Debt To Equity | 0.12 % | |||
Book Value Per Share | 1.44 X | |||
Cash Flow From Operations | 90.78 M | |||
Earnings Per Share | 0.16 X | |||
Total Asset | 755.46 M | |||
About Winnergy Medical Performance
By analyzing Winnergy Medical's fundamental ratios, stakeholders can gain valuable insights into Winnergy Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Winnergy Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Winnergy Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Winnergy Medical Public Company Limited imports and distributes medical and diagnostic products in China. Winnergy Medical Public Company Limited was founded in 2004 and is headquartered in Bangkok, Thailand. WINNERGY MEDICAL operates under Medical Distribution classification in Thailand and is traded on Stock Exchange of Thailand.Things to note about Winnergy Medical Public performance evaluation
Checking the ongoing alerts about Winnergy Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Winnergy Medical Public help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Winnergy Medical may become a speculative penny stock | |
About 74.0% of the company outstanding shares are owned by insiders |
- Analyzing Winnergy Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Winnergy Medical's stock is overvalued or undervalued compared to its peers.
- Examining Winnergy Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Winnergy Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Winnergy Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Winnergy Medical's stock. These opinions can provide insight into Winnergy Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Winnergy Stock analysis
When running Winnergy Medical's price analysis, check to measure Winnergy Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Winnergy Medical is operating at the current time. Most of Winnergy Medical's value examination focuses on studying past and present price action to predict the probability of Winnergy Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Winnergy Medical's price. Additionally, you may evaluate how the addition of Winnergy Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |